Ilex Medical Ltd (ILX) Fair Value & Analysis
Healthcare · Il · Market cap 547M ILA
Fair value as of: Jun 25, 2026
Analysis
Ilex Medical Ltd (ILX) currently trades at 47.37 ILA, while our model-based Fair Value estimate is 94.10 ILA — implying the stock looks roughly 98.6% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Ilex Medical Ltd engages in the import, marketing, distribution and sale of medical laboratory equipment and various diagnostic products, diagnostic systems, and kits and consumables in Israel, the United States, and internationally. The company also provides laboratory services, as well as is involved in the development, production, marketing and sale of software systems for information management in medical laboratories. Its products are used for performing tests in hospital medical laboratories, blood banks and health insurance funds, as well as for providing application and technical services to users. Ilex Medical Ltd was incorporated in 1990 and is based in Petah Tikva, Israel.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Ilex Medical Ltd (ILX) undervalued?
What is the fair value of ILX?
What is the quality score of ILX?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.